Searle Synarel
Executive Summary
Efficacy supplement revising "clinical pharmacology" section of nafarelin nasal solution approved Dec. 24. Revised labeling states that a 400 mcg daily dose of Synarel was shown to be clinically comparable to intramuscular leuprolide depot 3.75 mg monthly (TAP's Lupron Depot) for the treatment of symptoms associated with endometriosis